Literature DB >> 5100978

Cholera reinfection in man.

W E Woodward.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1971        PMID： 5100978     DOI： 10.1093/infdis/123.1.61

Source DB:  PubMed          Journal:  J Infect Dis        ISSN： 0022-1899            Impact factor:   5.226


× No keyword cloud information.
  10 in total

1.  Adoptive transfer of gut mucosal antitoxin memory by isolated B cells 1 year after oral immunization with cholera toxin.

Authors:  N Lycke; J Holmgren
Journal:  Infect Immun       Date:  1989-04       Impact factor: 3.441

2.  Frequency of reexposure to Vibrio cholerae O1 evaluated by subsequent vibriocidal titer rise after an episode of severe cholera in a highly endemic area in Bangladesh.

Authors:  Ana A Weil; Fahima Chowdhury; Ashraful I Khan; Daniel T Leung; Taher Uddin; Yasmin Ara Begum; Nirod Chandra Saha; Richelle C Charles; Regina C Larocque; Jason B Harris; Edward T Ryan; Firdausi Qadri; Stephen B Calderwood
Journal:  Am J Trop Med Hyg       Date:  2012-09-10       Impact factor: 2.345

Review 3.  Infectious diseases: annual review of significant publications.

Authors:  H A Reimann
Journal:  Postgrad Med J       Date:  1972-06       Impact factor: 2.401

Review 4.  Cholera.

Authors:  J B Kaper; J G Morris; M M Levine
Journal:  Clin Microbiol Rev       Date:  1995-01       Impact factor: 26.132

5.  Natural cholera infection-derived immunity in an endemic setting.

Authors:  Mohammad Ali; Michael Emch; Jin Kyung Park; Mohammad Yunus; John Clemens
Journal:  J Infect Dis       Date:  2011-09-15       Impact factor: 5.226

6.  Comparison of clinical features and immunological parameters of patients with dehydrating diarrhoea infected with Inaba or Ogawa serotypes of Vibrio cholerae O1.

Authors:  Ashraful I Khan; Fahima Chowdhury; Jason B Harris; Regina C Larocque; Abu S G Faruque; Edward T Ryan; Stephen B Calderwood; Firdausi Qadri
Journal:  Scand J Infect Dis       Date:  2010

7.  Antibacterial and antitoxin responses in the serum and milk of cholera patients.

Authors:  A S Majumdar; P Dutta; D Dutta; A C Ghose
Journal:  Infect Immun       Date:  1981-04       Impact factor: 3.441

8.  Phase 1 evaluation of Vibrio cholerae O1, serotype Inaba, polysaccharide-cholera toxin conjugates in adult volunteers.

Authors:  R K Gupta; D N Taylor; D A Bryla; J B Robbins; S C Szu
Journal:  Infect Immun       Date:  1998-07       Impact factor: 3.441

9.  Re-emergence of Cholera in the Americas: Risks, Susceptibility, and Ecology.

Authors:  Mathieu Jp Poirier; Ricardo Izurieta; Sharad S Malavade; Michael D McDonald
Journal:  J Glob Infect Dis       Date:  2012-07

10.  Descriptive epidemiology of cholera outbreak in Nigeria, January-November, 2018: implications for the global roadmap strategy.

Authors:  Kelly Osezele Elimian; Anwar Musah; Somto Mezue; Oyeronke Oyebanji; Sebastian Yennan; Arisekola Jinadu; Nanpring Williams; Adesola Ogunleye; Ibrahima Soce Fall; Michel Yao; Womi-Eteng Eteng; Patrick Abok; Michael Popoola; Martin Chukwuji; Linda Haj Omar; Eme Ekeng; Thieno Balde; Ibrahim Mamadu; Ayodele Adeyemo; Geoffrey Namara; Ifeanyi Okudo; Wondimagegnehu Alemu; Clement Peter; Chikwe Ihekweazu
Journal:  BMC Public Health       Date:  2019-09-13       Impact factor: 3.295
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.